ESMO Guidance for Reporting Oncology real-World evidence (GROW)
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 34(2023), 12 vom: 04. Dez., Seite 1097-1112 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Castelo-Branco, L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ESMO-GROW |
|---|
| Anmerkungen: |
Date Completed 21.12.2023 Date Revised 06.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.annonc.2023.10.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363407049 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363407049 | ||
| 003 | DE-627 | ||
| 005 | 20240306232456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2023.10.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1318.xml |
| 035 | |a (DE-627)NLM363407049 | ||
| 035 | |a (NLM)37848160 | ||
| 035 | |a (PII)S0923-7534(23)04018-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Castelo-Branco, L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ESMO Guidance for Reporting Oncology real-World evidence (GROW) |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2023 | ||
| 500 | |a Date Revised 06.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a ESMO-GROW | |
| 650 | 4 | |a guidance | |
| 650 | 4 | |a observational studies | |
| 650 | 4 | |a oncology | |
| 650 | 4 | |a real-world data | |
| 650 | 4 | |a real-world evidence | |
| 700 | 1 | |a Pellat, A |e verfasserin |4 aut | |
| 700 | 1 | |a Martins-Branco, D |e verfasserin |4 aut | |
| 700 | 1 | |a Valachis, A |e verfasserin |4 aut | |
| 700 | 1 | |a Derksen, J W G |e verfasserin |4 aut | |
| 700 | 1 | |a Suijkerbuijk, K P M |e verfasserin |4 aut | |
| 700 | 1 | |a Dafni, U |e verfasserin |4 aut | |
| 700 | 1 | |a Dellaporta, T |e verfasserin |4 aut | |
| 700 | 1 | |a Vogel, A |e verfasserin |4 aut | |
| 700 | 1 | |a Prelaj, A |e verfasserin |4 aut | |
| 700 | 1 | |a Groenwold, R H H |e verfasserin |4 aut | |
| 700 | 1 | |a Martins, H |e verfasserin |4 aut | |
| 700 | 1 | |a Stahel, R |e verfasserin |4 aut | |
| 700 | 1 | |a Bliss, J |e verfasserin |4 aut | |
| 700 | 1 | |a Kather, J |e verfasserin |4 aut | |
| 700 | 1 | |a Ribelles, N |e verfasserin |4 aut | |
| 700 | 1 | |a Perrone, F |e verfasserin |4 aut | |
| 700 | 1 | |a Hall, P S |e verfasserin |4 aut | |
| 700 | 1 | |a Dienstmann, R |e verfasserin |4 aut | |
| 700 | 1 | |a Booth, C M |e verfasserin |4 aut | |
| 700 | 1 | |a Pentheroudakis, G |e verfasserin |4 aut | |
| 700 | 1 | |a Delaloge, S |e verfasserin |4 aut | |
| 700 | 1 | |a Koopman, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 34(2023), 12 vom: 04. Dez., Seite 1097-1112 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2023 |g number:12 |g day:04 |g month:12 |g pages:1097-1112 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2023.10.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2023 |e 12 |b 04 |c 12 |h 1097-1112 | ||